Risk, reward and the AstraZeneca vaccine
Today in Focus - Podcast tekijän mukaan The Guardian
People in the UK under 30 will be offered an alternative to the AstraZeneca vaccine because of a possible link to rare blood clots. Could the move dent confidence in the widely used jab?. Help support our independent journalism at <a href="https://www.theguardian.com/infocus">theguardian.com/infocus</a>
